Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B

Lung-Yi Mak, Danny Wong, Alison Kuchta, Martina Hilfiker, Aaron Hamilton, Ning Chow, XianHua Mao, Wai Kay Seto, Man-Fung Yuen

Clin Mol Hepatol. 2023;29(1):146-162. Published online August 19, 2022

DOI: https://doi.org/10.3350/cmh.2022.0172

View: 5164 Download: 219 Web of Science: 9 Crossref: 9

Editorial

Risk of hepatocellular carcinoma in untreated patients with chronic hepatitis B: Independent of HBeAg status?

Ho Soo Chun, Minjong Lee

Clin Mol Hepatol. 2021;27(3):448-450. Published online June 23, 2021

DOI: https://doi.org/10.3350/cmh.2021.0130

View: 3712 Download: 118 Web of Science: 1 Crossref: 1

Original Article

Characterization and evaluation of liver fibrosis grade in patients with chronic hepatitis B virus infection and normal transaminases

San Juan López Cristina, Casado Martín Marta, González Sánchez Mercedes, Porcel Martín Almudena, Hernández Martínez Álvaro, Vega Sáenz Jose Luis, Parrón Carreño Tesifón

Clin Mol Hepatol. 2018;24(4):384-391. Published online July 4, 2018

DOI: https://doi.org/10.3350/cmh.2018.0004

View: 7669 Download: 196 Web of Science: 11 Crossref: 10

3

Comparison of Lamivudine-induced HBsAg Loss rate according to age in children with chronic hepatitis B

Jung Mi Kim , Byung Ho Choe , Mi Ae Chu , Seung Man Cho

Clin Mol Hepatol. 2009;15(2):168-178. Published online June 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.2.168

View: 4332 Download: 41 Crossref: 3

Clinical Outcomes of Lamivudine Therapy in HBeAg Positive Chronic Hepatitis B with Minimally Elevated ALT

Dong Ha Han , Neung Hwa Park , Jung Woo Shin , Seok Won Jung , Young Tae Hwang , Hyun Soo Kim , In Du Jeong , Sung Jo Bang , Do Ha Kim

Clin Mol Hepatol. 2007;13(2):146-156. Published online January 1, 1970

View: 2691 Download: 20

Natural History of HBeAg Negative Chronic Hepatitis B Virus Infection; A Cohort Study

Chang Mo Moon, M.D., Do Young Kim, M.D., Ki Jun Song, Ph.D. Ja Kyung Kim, M.D., Hyun Woong Lee, M.D., Jung Min Lee, M.D., Ki Tae Yoon, M.D., Yong Han Paik, M.D., Dong Ki Kim, Ph.D. Kwang-Hyub Han, M.D., Chae Yoon Chon, M.D., Young Myoung Moon, M.D., and Sang Hoon Ahn, M.D.

Clin Mol Hepatol. 2006;12(2):163-172. Published online January 1, 1970

View: 2266 Download: 26

1

Clinical Significance and Natural History of "HBeAg Negativity" in Patients with Chronic HBV Infection

Young Sok Lee

Clin Mol Hepatol. 2006;12(2):133-135. Published online January 1, 1970

View: 2414 Download: 17

1 |

Viewed By 5077	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4904	MAFLD: How is it different from NAFLD?
Viewed By 4822	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3524	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3502	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 67	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 49	MAFLD enhances clinical practice for liver disease in the Asia-Pacific region

Search